治疗性超声对离体胰腺模型释放胰岛素、胰高血糖素和α-淀粉酶的影响
研究将治疗性超声参数(800 kHz,ISPTA 0.5-1 W/cm²,5分钟)应用于兔胰腺组织块培养模型(每组n=6)及少量人胰岛(每组n=3),测量胰岛素、胰高血糖素和α-淀粉酶释放。结果显示800 kHz、1 W/cm²超声组在t=5分钟时胰岛素释放增加(P<.005),而胰高血糖素和α-淀粉酶浓度与假处理组无统计学显著差异,组织完整性未见明显受影响。
要点
- 治疗性超声(800 kHz,1 W/cm²,5分钟)可增加离体兔胰腺组织胰岛素释放(P<.005)。
- 超声未显著改变胰高血糖素和α-淀粉酶释放,组织完整性未见明显影响。
- 人胰岛初步研究似遵循兔胰腺研究的趋势。
关键影像表现/征象
- 假处理兔胰腺样本细胞外胰岛素含量下降,而800 kHz、1 W/cm²超声处理样本在t=5分钟时胰岛素释放增加(P<.005)。
- t=35分钟时未检测到进一步的胰岛素释放。
- 超声处理组与假处理组兔胰腺的细胞外胰高血糖素和α-淀粉酶浓度无统计学显著差异。
- 人胰岛初步研究似遵循兔胰腺研究观察到的趋势。
- 组织学分析显示胰岛及其他胰腺组织完整性未似受超声处理影响。
局限性
- 人胰岛初步研究仅在小数量样本中进行(每组n=3)。
- 作者结论指出基于超声增强胰岛素释放的策略需要优化β细胞胰岛素分泌,同时尽量减少胰高血糖素和胰腺酶分泌。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Our previously published studies showed the potential of therapeutic ultrasound (US) as a novel non-pharmacological alternative for the treatment of secretory deficiencies in type 2 diabetes. Despite showing enhanced insulin release from beta cells, these studies did not explore the potential effects of US treatment on other cells in the islets of Langerhans such as glucagon-secreting alpha cells or acinar cells of the exocrine pancreas.
METHODS: We applied US parameters found capable of safely stimulating insulin secretion from pancreatic beta cells (f = 800 kHz, ISPTA = 0.5-1 W/cm2 , 5 minutes) to a diced rabbit pancreas model in culture plates (n = 6 per group). Released quantities of insulin and glucagon in response to US treatment were measured by collecting aliquots of the extracellular medium prior to the start of the treatment (t = 0 minute), immediately after treatment (t = 5 minutes) and 30 minutes after the end of treatment (t = 35 minutes). Potential release of digestive enzyme alpha-amylase as a result of US treatment was evaluated in rabbit pancreas experiments. Preliminary studies were also performed in a small number of human pancreatic islets in culture plates (n = 3 per group). The general integrity of the US-treated rabbit pancreatic tissue and human pancreatic islets was evaluated through histological analysis.
RESULTS: While sham-treated rabbit pancreas samples showed decreased extracellular insulin content, there was an increase in insulin release at t = 5 minutes from samples treated with US at 800 kHz and 1 W/cm2 (P <.005). Furthermore, no further insulin release was detected at t = 35 minutes. No statistically significant difference in extracellular glucagon and alpha-amylase concentrations was observed between US-treated and sham rabbit pancreas groups. Preliminary studies in human islets appeared to follow trends observed in rabbit pancreas studies. Islet and other pancreatic tissue integrity did not appear to be affected by the US treatment.
CONCLUSION: A potential US-based strategy for enhanced insulin release would require optimization of insulin secretion from pancreatic beta cells while minimizing glucagon and pancreatic enzyme secretions.
引用
- Suarez-Castellanos I, Singh T, Chatterjee Bhowmick D, et al. Effect of Therapeutic Ultrasound on the Release of Insulin, Glucagon, and Alpha-Amylase from Ex Vivo Pancreatic Models. J Ultrasound Med. 2021. PMID: 33595146. doi:10.1002/jum.15661
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。